Oral Bisphosphonates as a Cause of Bisphosphonate-Related Osteonecrosis of the Jaws: Clinical Findings, Assessment of Risks, and Preventive Strategies

Once-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis

Dennis M. Black, Pierre D. Delmas, Richard Eastell et al. · New England Journal of Medicine · 2007 · 3K citations · Full text

Medicine, Pharmacotherapy, Bone Augmentation +16

Zoledronic Acid and Clinical Fractures and Mortality after Hip Fracture

Kenneth W. Lyles, Cathleen Colón‐Emeric, Jay Magaziner et al. · New England Journal of Medicine · 2007 · 2K citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +11

Effects of Continuing or Stopping Alendronate After 5 Years of Treatment

Dennis M. Black, Ann V. Schwartz, Kristine E. Ensrud et al. · JAMA · 2006 · 1.4K citations

Medicine, Pharmacotherapy, Bone Metabolism +16

Ten Years' Experience with Alendronate for Osteoporosis in Postmenopausal Women

Henry G. Bone, David Hosking, Jean‐Pierre Devogelaer et al. · New England Journal of Medicine · 2004 · 1.4K citations · Full text

Medicine, Pharmacotherapy, Bone Metabolism +13

Oral Bisphosphonate-Induced Osteonecrosis: Risk Factors, Prediction of Risk Using Serum CTX Testing, Prevention, and Treatment

Joseph E. Cillo, Juan J. Ulloa · Journal of Oral and Maxillofacial Surgery · 2007 · 718 citations

Dentistry, Oral Medicine, Preventive Dentistry +15